BigGovHealth Improve and Strengthen Health Care for all Americans
Video Testimonials
Dorothy Griffiths (Stoke-on-Trent, United Kingdom)
Dorothy “Dot” Griffiths is a breast cancer patient and a nationally recognized advocate for enacting reforms within the United Kingdom’s National Health Service – the government-run entity that controls health care services in England, Scotland and Northern Ireland.
In July 2005, Griffiths organized the advocacy group “Fighting for Herceptin” and successful lobbied the British Parliament after the NHS refused her request to for the life-prolonging breast cancer drug Herceptin because of the cost of the treatment.
Three years later, Dorothy continues to be a cancer survivor and advocate for women and breast cancer, pushing the NHS to offer Herceptin treatment. However, the drug can still only be prescribed to women with advanced breast cancer. Recent clinical trials overwhelmingly show that the drug also has positive effects for many women with early-stage breast cancer.
Patient Testimonials
- Brian Lee Crowley (Halifax, Novia Scotia, Canada)
- Brian Turner (Oaks Green Mount, Rastrick, United Kingdom)
- Dorothy Griffiths (Stoke-on-Trent, United Kingdom)
- Dr. David Zitner (Halifax, Novia Scotia, Canada)
- Grace Paterson (Halifax, Novia Scotia, Canada)
- Helen Evans (London, United Kingdom)
- Richard Newman and his son Roy (Calgary, Alberta, Canada)
- Shona Holmes (Toronto, Ontario, Canada)
- Tim Evans (London, United Kingdom)
- Highlights
- < Back to Overview
Health Care Fact of the Day
A typical Canadian seeking surgical or other therapeutic treatment had to wait 18.3 weeks in 2007, an all-time high, according to The Fraser Institute....learn more.
About the Center for Medicine
The Center for Medicine in the Public Interest (CMPI) is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make healthcare more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.